Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness

Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four ...

LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System

Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutesCAMBRIDGE, United Kingdom, Feb. 16, 2026 (GLOBE NEWSWIRE) -- LEX Diagnostics, ...
Medscape

Speeding Respiratory Infection Diagnosis in Rural Areas

A collaboration between a rural, urgent care center network and diagnostics company may be laying the groundwork for speeding ...
Technology Networks

Faster, More Accurate Testing for BV and Candida

Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...
Le Lézard

Visby Medical Collaborates with Watchmaker Genomics to Enhance Respiratory Pathogen Detection in the At-Home Setting

Visby Medical, a leading innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration ...
Business Weekly

FDA clearance and CLIA waived status for LEX Diagnostics platform

LEX Diagnostics, a Cambridgeshire-based innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CLIA waived status for a platform that could ...
Pharmabiz

LEX Diagnostics receives US FDA 510(k) clearance and CLIA waiver for LEX VELO system

LEX Diagnostics receives US FDA 510(k) clearance and CLIA waiver for LEX VELO system: Cambridgeshire, UK Tuesday, February 17, 2026, 17:00 Hrs [IST] LEX Diagnostics, a leading inn ...
PharmiWeb

Molecular Infectious Disease Testing Market Research Report, Size, Share, Analysis, Growth by Forecast to 2031

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
Fierce Biotech

ILiAD Biotechnologies snags $115M series B for whooping cough vaccine

ILiAD Biotechnologies has closed an oversubscribed $115 million series B fundraise to support the company’s next-generation ...

Promising New Test To Detect Parasites In Farmed Deer

Deer at the Bioeconomy Science Institute's Invermay farm, near Mosgiel. Photo/Supplied. Researchers have discovered a more ...
The Malaysian Reserve

Genotyping Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...

ABL Diagnostics Strengthens Strategic Supplier Agreements to Support Accelerated Growth

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized contractual terms, and enhanced supply security. These improvements will ...